Topics

Articles

A cohort study digs into whether there is an improvement in overall survival or quality of life within five years of the FDA granting accelerated approval to oncology drugs. 

Evaluating the Long-Term Clinical Benefit of Cancer Treatments Granted Accelerated Approval

If manufacturers cannot ensure safe, cost-effective delivery of treatments for rare diseases, access will remain a challenges for many patients living with these conditions.

How Efficient Cold Chain Logistics Can Change the Lives of Rare Disease Patients

Pharma Commerce makes a return trip to Philly for insights on the latest approaches in patient assistance and adherence.

An 'Access' Double-Take: Fresh Views on PAPs and Patient Hubs

Cohort study examines the potential for spending to significantly decrease for individuals who use these generic versions of biologics. 

Does Biosimilar Competition Result in Lower Out-of-Pocket Costs for Patients?

Maria Kirsch is President of Patient Services at EVERSANA. 

Why manufacturers should leverage technology to address low adherence rates.


The Power of Patient Adherence Tools to Improve the Patient Journey

Syneos Health's Kim Plesnarski uncovers the key issues that customers are currently trying to address, including the retail shift from small-molecule products to biologics. 

Tackling Patient-Related Challenges Along the Pharma Supply Chain

Patients should not have to wait to access the medication they need.

Fail-First Policies Are Harming Patients

Podcasts

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency. 

A Further Examination of Pharmacy Benefit Managers

The new option will help patients receive life-saving medications at an even quicker rate.

New York City, Los Angeles Will Now Offer Amazon Pharmacy Same-Day Delivery

A study of patients with the long-term conditions who are required to switch to high-deductible health plans could potentially be more likely to experience diabetes complications than those who stay in standard insurance plans.

Patient Support